Lenacapavir: Could This Drug END The HIV Epidemic?

This video explores lenacapavir, a groundbreaking HIV prevention medication that's changing the landscape of PrEP (pre-exposure prophylaxis). Administered as a subcutaneous injection just twice a year, lenacapavir offers a convenient alternative to daily oral PrEP pills. We'll dive into the results of the PURPOSE 1 trial, which demonstrated 100% efficacy in preventing HIV infections among cisgender women and adolescent girls. The video will cover lenacapavir's unique mechanism as an HIV-1 capsid inhibitor, its potential benefits in overcoming adherence challenges, and its promising future in HIV prevention strategies. We'll also discuss the drug's safety profile, potential side effects, and its significance in expanding HIV prevention options, particularly for populations at high risk of HIV acquisition Connect With Me- Instagram-   / abhishekkatiyaryt   TikTok- https://www.tiktok.com/@abhishekkatiy... Patreon-   / membership   Buy Me A Coffee- http://buymeacoffee.com/AbhishekYT